Information Provided By: 
Fly News Breaks for February 6, 2019
CNC
Feb 6, 2019 | 08:20 EDT
Oppenheimer analyst Michael Wiederhorn lowered his price target for Centene to $83 from $165 to reflect split. The analyst notes that the company's Q4 results were solid, and its outlook remains strong, given the growth and stability of the ACA business, and the potential for $500M in savings over many years from the Centene Forward initiative. Given the strong prospects and attractive valuation, he reiterates an Outperform rating on the shares.
News For CNC From the Last 2 Days
